Trade Mark Journal No.2026/031 31 July 2026
UK00004418500 20 July 2026 (9,35,42)
OptiOpioid
- Class 9
- Software for use in healthcare; clinical decision support software; software for analysing medication data; software for identifying medications; software for calculating oral morphine equivalent doses; software for assessing and reporting medication-related risk information; software for use in perioperative care pathways; software for supporting preoperative assessment; software for identifying patients for referral into clinical pathways; computer software for use in medical decision support systems; software as a medical device [SaMD], downloadable; downloadable electronic reports generated by the aforesaid software.
- Class 35
- Compilation, processing and analysis of medical, healthcare and pharmaceutical data; provision of healthcare management information; collection and systemisation of medical, healthcare and pharmaceutical information into computer databases; preparation of reports and management information derived from medical, healthcare and pharmaceutical data; information, advisory and consultancy services relating to the aforesaid services.
- Class 42
- Software as a service (SaaS); platform as a service (PaaS); providing temporary use of non-downloadable software; providing temporary use of non-downloadable medical software; hosting of software and databases; cloud computing services; design, development, maintenance and updating of computer software; design, development, maintenance and updating of medical software; software engineering services; software testing and quality assurance services; development of clinical decision support software; development of software for medication management and healthcare risk identification; electronic storage of healthcare data and medical records; technological consultancy relating to healthcare software and digital health systems; information technology services; scientific and technological services relating to computer software for healthcare applications; information, advisory and consultancy services relating to the aforesaid services; all of the aforesaid services for the pharmaceutical, medical and healthcare industries.
Guard-Rx Ltd
Representative: Mills & Reeve LLP